Study links weight-loss drug to rare eye condition Published People prescribed semaglutide, sold as Ozempic and Wegovy, to lose weight, may have a higher risk of developing a serious but rare eye condition, a study suggests
No, discard it
Ozempic, whose active ingredient is semaglutide, was originally designed to help people with type 2 diabetes manage blood sugar levels
During an active shortage, the FDA exercises enforcement discretion that allows compounding pharmacies to produce the medication
According to law enforcement, the defendant used two pill presses to manufacture counterfeit pharmaceutical pills that contained methamphetamine, fentanyl, and cocaine
that prescription is fulfilled by either a retail or a compounding pharmacy